Exponent Inc (EXPO) 50.70 $EXPO Ex-Dividend Reminder:

New Post Public Reply Private Reply Replies (0) Message Board

Sep 3, 2016 at 11:01 PM

Exponent Inc (EXPO) 50.70 $EXPO

Ex-Dividend Reminder: Exponent, Ensco and Knight Transportation
DividendChannel.com - Mon Aug 29, 9:07AM CDT
Looking at the universe of stocks we cover at Dividend Channel, on 8/31/16, Exponent Inc. , Ensco plc , and Knight Transportation Inc.
EXPO: 50.70 (+0.12)

What Makes Exponent (EXPO) a Strong Sell?
Zacks Equity Research - Zacks Investment Research - Fri Aug 05, 7:42AM CDT
One stock that you may want to consider dropping is Exponent Inc. (EXPO), which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year
EXPO: 50.70 (+0.12), CLGX: 41.45 (+0.22)

Exponent Appoints Dr. Catherine Corrigan to President
GlobeNewswire - Fri Jul 29, 1:00PM CDT
Exponent, Inc. (Nasdaq:EXPO) announced today the appointment of Dr. Catherine Corrigan to the position of President, reporting to Dr. Paul Johnston, CEO.
EXPO: 50.70 (+0.12)

ABM Industries Hits 52-Week High on Strategic Initiatives
Zacks Equity Research - Zacks Investment Research - Tue May 31, 7:28AM CDT
Shares of the leading facility solutions provider ABM Industries Incorporated (ABM) scaled a new 52-week high of $34.13 during Friday's trading session.
CBZ: 11.23 (unch), EXPO: 50.70 (+0.12), CEB: 58.98 (+0.57), ABM: 38.91 (+0.25)

ABM Remains Poised for Healthy Growth on Vision 2020 Plan
Zacks Equity Research - Zacks Investment Research - Mon May 30, 6:04AM CDT
On May 30, Zacks Investment Research updated the research report on leading provider of facility solutions, ABM Industries Inc. (ABM).
CBZ: 11.23 (unch), EXPO: 50.70 (+0.12), CEB: 58.98 (+0.57), ABM: 38.91 (+0.25)

Navigant (NCI) Beats on Q1 Earnings, Reiterates Guidance
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 9:07AM CDT
Navigant Consulting Inc.(NCI) reported adjusted earnings per share of 27 cents in first-quarter 2016, compared with 23 cents in the prior-year quarter. Adjusted earnings comfortably beat the Zacks Consensus Estimate of 22 cents.
EXPO: 50.70 (+0.12), IT: 91.43 (+0.64), ACN: 115.66 (+0.60), NCI: 19.86 (+0.18)

Exponent posts 1Q profit
Automated Insights - Wed Apr 20, 4:07PM CDT
MENLO PARK, Calif. (AP) _ Exponent Inc. (EXPO) on Wednesday reported first-quarter earnings of $15.4 million.
EXPO: 50.70 (+0.12)

Exponent Declares Regular Quarterly Dividend
GlobeNewswire - Wed Apr 20, 3:05PM CDT
Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.18 per share of common stock to be paid on June 24, 2016 to all common stockholders of record as of June 10, 2016.
EXPO: 50.70 (+0.12)

Exponent Reports First Quarter Fiscal Year 2016 Financial Results
GlobeNewswire - Wed Apr 20, 3:05PM CDT
Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the first quarter ended April 1, 2016.
EXPO: 50.70 (+0.12)

MyoKardia Names Mary Cranston to Board of Directors
GlobeNewswire - Wed Apr 13, 6:30AM CDT
MyoKardia, Inc. (Nasdaq:MYOK), a clinical stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases, today announced the appointment of Mary Cranston to its board of directors and as chair of the audit committee. Ms. Cranston is a retired senior partner of Pillsbury Winthrop Shaw Pittman LLP, an international law firm. She was formerly chair and chief executive officer of Pillsbury.
V: 82.00 (+0.70), EXPO: 50.70 (+0.12), MYOK: 21.56 (+0.25), IRF: 39.98 (-0.01), JNPR: 23.41 (+0.10)

Exponent to Announce First Quarter of Fiscal Year 2016 Results and Host Quarterly Conference Call on April 20
GlobeNewswire - Wed Apr 06, 8:10AM CDT
Exponent, Inc. (Nasdaq:EXPO), today announced that it will report first quarter of fiscal year 2016 financial results for the period ended April 1, 2016 following the close of the market on Wednesday, April 20, 2016. On that day, Dr. Paul Johnston, President and Chief Executive Officer, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results.
EXPO: 50.70 (+0.12)

CRA International Appoints Vice President, Finance Practice
Zacks Equity Research - Zacks Investment Research - Fri Apr 01, 3:20PM CDT
CRA International Inc. (CRAI), a leading consulting service firm, recently announced the joining of James Massey as its vice president in the Finance Practice division in Dallas.
NVEE: 31.45 (+0.16), CBZ: 11.23 (unch), EXPO: 50.70 (+0.12), CRAI: 26.73 (+0.21)

Stantec Eyes Expansion, to Acquire MWH Global for $795M
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 1:50PM CDT
Stantec Inc. (STN), a leading engineering firm based in Canada, recently inked a merger agreement to acquire MWH Global, Inc. ("MWH"

.
NVEE: 31.45 (+0.16), CBZ: 11.23 (unch), EXPO: 50.70 (+0.12), STN: 24.26 (+0.40)

Cintas (CTAS) Remains Bullish with Healthy Organic Growth
Zacks Equity Research - Zacks Investment Research - Thu Mar 24, 1:20PM CDT
On Mar 24, Zacks Investment Research updated the research report on business services provider Cintas Corporation (CTAS).
CBZ: 11.23 (unch), EXPO: 50.70 (+0.12), CTAS: 118.84 (+1.14), HCKT: 16.63 (+0.20)

Omnicom Q4 Earnings in Line, Revenues Down Y/Y
Zacks Equity Research - Zacks Investment Research - Tue Feb 09, 2:14PM CST
Omnicom Group Inc (OMC) reported net income of $331.6 million or $1.35 per share in the fourth quarter of 2015, versus $329.5 million or $1.30 per share in the year-ago quarter.
YUME: 3.38 (+0.04), OMC: 86.70 (+0.45), EXPO: 50.70 (+0.12), IPG: 23.01 (+0.04)

Stericycle (SRCL) Beats on Q4 Earnings, Revenues Up Y/Y
Zacks Equity Research - Zacks Investment Research - Fri Feb 05, 9:40AM CST
Stericycle, Inc (SRCL) reported fourth-quarter 2015 results with adjusted earnings of $1.11 per share versus $1.12 in the year-ago quarter
EXPO: 50.70 (+0.12), FC: 16.22 (+0.05), SRCL: 84.15 (-1.21), NCI: 19.86 (+0.18)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ortho Molecular and HANS: Streamlining Functional Medicine

Functional Medicine Gets a Tech Boost The world of functional medicine just got a major shot in the arm, courtesy of an intriguing alliance between Ortho Molecular Products and HANS.FM. First of all, let's address the elephant in the room: clinicians in this field aren't exactly on a coffee break. They’re buried under mountains of paperwork, often spending hours just...

CURE Intl and Thoughtworks Step Into Digital Era

Pushing Paper Out, Digitizing In In a world where tech is king, why were hospitals—crucial, life-saving institutions—still bogged down by dusty folders and ink smudges? Well, not anymore for CURE International, not with Thoughtworks stepping up to the plate. This ain't just swapping paper for pixels; it's a lifeline for kids getting world-class surgical care without...

Jinko Solar Joins B20 Summit: Energy Forefront Focus

Jinko Solar's Invitation to the B20 Summit Never a dull moment in the solar space, especially when Jinko Solar, a big shot in clean energy, jumps into the spotlight at the B20 Summit in the U.S. Awash with high-profile discussions, Jinko's not just chatting—it's the only photovoltaic firm strutting its stuff in D.C. with gutsy calls for energy reform. Key Takeaways from...

Jubilant Eyes MPN Breakthrough with JBI-802 Data at ASH

Presenting the Case for JBI-802 From the bustling circus of drug development, here comes Jubilant Therapeutics, strutting their stuff with JBI-802, a dual inhibitor designed to tackle myeloproliferative neoplasms (MPNs) with a one-two punch. Now, they're set to drop some spicy deets at the 68th ASH Annual Meeting in New Orleans this December. So what's the fuss about?...

Agilyx's Q3 Update: GreenDot Shines Amid Mixed Results

Peeking into Agilyx's Financial Odyssey Just as I sip my morning coffee pondering the highs and lows of the market, here comes Agilyx ASA splashing some liquidity on the scene. The Q3 report paints the company in various shades—from solid greens to hesitant reds. Nothing like the thrill of untangling mixed results over a quiet day, huh? GreenDot's Climb to Profitability...

Inflatable Wonders Turn Christmas into a Hoot at Lowe's

Inflatables Bringing the Cheer (and Laughs) Well, it's that season again—where decorations either have us grumbling at the electric bill or chuckling at the lawn art. Lowe's has teamed up with Gemmy to serve a heaping platter of holiday giggles this year. They've rolled out a quirky lineup of inflatables that go from shivering Highland cows to dinosaurs and elves....

LG Innotek Scores Hat Trick with CES Innovation Wins

LG Innotek's Lighting Triumph Here we go again, LG Innotek just snagged their third CES Innovation Award in a row, this time for their cutting-edge vehicle lighting module, Nexlide C+. It's one for the books—breaking into the 2027 CES spotlight with innovative tech that not only grabs the eyes but could also steal the hearts of investors willing to bet on the future of...

RF MEDICAL Expands into Europe with New CE Certification

RF MEDICAL Secures CE Marking for Mi-BLATOR™ Just when you think the European medical device market's hit its saturation point, RF MEDICAL decides to kick the door open with their Mi-BLATOR™ microwave ablation system. This ain't just another plastic gadget, folks; it's got that shiny new CE marking under the European Union's Medical Device Regulation (MDR). Now, what...

BD Sets Stage for Investor Day in December 2026

BD's Investor Day: A Peek into the Future Say what you will about investor meets, but BD (Becton, Dickinson and Company) throwing its shindig on December 10, 2026, could be a highlight on the calendar if you're eyeing the medical technology sector. Scheduled in New York, this event is gearing up to be a canvas for BD's higher-ups to sketch out their roadmap. If you’re...

Centrus Energy Welcomes Nuclear Veteran to Leadership

Navigating a New Era at Centrus When you hear about seasoned veterans stepping up to the plate in the energy sector, it's time to perk up your ears. Centrus Energy (NYSE:LEU), a big player in nuclear fuel, just added Kevin Graney to their Board of Directors. This isn't your run-of-the-mill appointment; it packs nearly three decades of nuclear tech and national security...